Tumor cells can protect themselves in vitro and in vivo against immune assault by such mechanisms as the secretion of nonspecific suppressive or anti-inflammatory factors (1) or the shedding of tumor-specific antigens (2). In this report we describe a further mechanism which can prevent immune effector cells from establishing contact with tumor cells in vitro and which, in so doing, inhibits lymphocyte-mediated cytolysis.
The optimal ratio of spleen cells to tumor cells for visualising the halos was =3.0 × 106 cm -2, i.e., just sufficient to form a cell sheet. 4 X 109 cm -2 formalin-fixed Corynebacterium parvum organisms were also used to visualise the halos as was Pelikan, shellac-free, drawing ink (Gunther Wagner, Hanover, Germany). It was found that the process of visualisation could be hastened by spinning the particles onto the cells using a conventional centrifuge with plate holder or a cytocentrifuge for the slide/coverslip preparations.
Microscopy. Whereas the halo phenomenon could readily be seen using a conventional inverted microscopy, it could be studied in greater detail if cells were plated on to circular coverslips and placed in a Dvorak-Stotler chamber (9; Zeiss, Ober Kochen, W. Germany) or if the coverslips were allowed to hang from the underside of a thin slide. Here they were examined and photographed under Nomarski optics on a Zeiss Universal microscope. For time-lapse studies, cells were plated on Falcon plastic dishes with Cooper lids (Becton Dickinson UK, Ltd., Middlesex) and filmed on a Wild inverted phase microscope (Wild, Heerbrugg, Switzerland) with Wild time-lapse equipment in a 37°C room (10) . Lapse rates of 10-100 s were used.
Enzymes. Hyaluronidase from bovine testis type 1 (Sigma, Kingston-on-Thames, England) and ovine testis (Sigma), both of which also degrade chondroitin sulphate, and hyaluronidase ex Streptomyces (l 1) grade B (Calbiochem, San Diego, Calif.) which is specific for hyaluronic acid, were used in the study. These enzymes had no detectable activity against the general proteolytic substrate azocoll (Calbiochem) and the activity of the fungal hyaluronidase was resistant to heating at 60°C for 30 min (11) . In other attempts to remove the barriers, cells were treated with concentrations of trypsin, pepsin, and pronase (BDH) varying from 0.02 to 0.0002% for 20 min at 37°C; 0.002% DNase I (Sigma), 15 min at 37°C; 0.02% RNase (Sigma), 15 min at 37°C; and 50 U/ml Vibrio cholerae neuraminidase (BDH), 15 min at 37°C. Tests were performed in Eagle's medium containing 10% FCS and in Dulbecco's phosphate-buffered saline (PBS); the enzymes were removed by washing and the cells were tested immediately for their ability to form halos using spleen cells as indicators.
Microcytotoxicity Tests. 104 tumor cells were plated in each well of a 96 well Microtitre plate
No. M29 ART (Sterilin). After overnight incubation, 10/~Ci Na51CrO4 (Radiochemicals Centre, Amersham, Bucks.) were added in 50 #l medium. After 2 h at 37°C, the wells were washed five times with warm Dulbecco's PBS and the appropriate number of spleen cells added to each well. After a further 7-h incubation period, the supernate was removed, the cells washed once in Dulbecco's PBS, and the label associated with the cells was released by treatment with 0.1 ml 2 N NaOH. The counts in the experimental wells were subtracted from those in control wells to which no spleen cells had been added; this value was then expressed as a percentage of the control counts to give the cytotoxic index. When required, cells were treated with 10 IU/ml (0.1-ml final volume) bovine testicular or fungal hyaluronidase during the labeling and also during the subsequent incubation periods.
Results
Our initial observations were made with C3Hf/Bu fibrosarcoma (Fsa) cells. Typically, after culture for longer than 2-4 h, ~80% of these cells prevented normal spleen cells from coming close to their cell membranes. The effect was made obvious by the presence of large translucent halos around the tumor cells which spleen cells were unable to penetrate (Figs. 1 a & 2 a) . No structure was visible in the halo region by either phase contrast, dark ground or Nomarski optics; the halos extended well beyond the filopodial attachments seen with high resolution microscopy ( Fig. 1 a) .
In one experiment halo sizes were measured; they ranged up to 17 #m, averaging 8.8 #m, from Fsa membrane to spleen cells; the minimum measurable size was 2/~m. Halos were formed by cells taken in vitro directly from a tumor or by cells subcuhured for up to at least 15 passages in vitro.
Time-lapse cinemicrography showed that at no time did spleen cells penetrate the halos; they were excluded even as they settled on to the surface of the dish, the settling pattern suggesting that the halos were not simply associated with the substratum hut The exclusion phenomenon was seen with particles other than normal spleen cells. Bacteria (Fig. 1 b) and carbon particles (Fig. l c) showed halo formation as did immune spleen cells, lymph node cells, thymocytes, normal peritoneal exudate cells, and erythrocytes. Visualisation of the halos was optimal when the concentration of indicator particles was sufficient to form a single layer sheet: at lower concentrations, the monolayer was insufficient to see halos, whereas at high concentrations, spleen cells piled up over both the Fsa cells and their halos. It was of interest that fixation of the tumor cells in 1% formal saline or 2.5% glutaraldehyde did not remove the barrier; after dehydration, however, the halos were no longer visible.
The C3Hf/Bu Fsa cells were not alone in their ability to exclude particles from the region around them. A variety of normal and tumor cells also were found to possess halos (Table 1) . A major exception, however, was the seven lymphoblastoid cell lines tested. Vero cells also appeared to be negative. It should, however, be noted that halos of <2/zm would not be demonstrable.
These barriers are similar to the hyaluronidase-sensitive material seen to surround synovial cells and fibroblasts in vitro (3, 4, 5) . We therefore examined the sensitivity of the halos formed by the cells detailed in Table 1 to bovine testicular hyaluronidase (10 IU/ml). Treatment with hyaluronidase removed the barrier so that the spleen cells were then able to approach the cell membranes (Fig. 2) ; with most cell types, the barrier was removed within 3 m, although certain of the carcinoma cells appeared to be slightly less sensitive. These concentrations of hyaluronidase appeared to have no adverse influence on the morphology or growth of the cells. After removal of the enzyme, the cells regenerated their ability to repel spleen cells within 2 h. Fungal (0.1-10 IU/ml) and ovine testicular (10 IU/ml) hyaluronidase where tested, had the same effect. Other enzymes (pronase, pepsin, trypsin, neuraminidase, collagenase, DNase, and RNase) did not remove the barrier when used at concentrations that did not obviously affect the morphology and adherence of the cells to glass.
These results show that many adherent sarcoma and carcinoma cells, as well as normal cells, are surrounded in vitro by hyaluronidase-sensitive zones that can prevent spleen cells as well as other cells and particles approaching their cell membranes. As it is thought that contact between effector and target cells is a prerequisite for cellmediated cytolysis (12), we have investigated the extent to which these halos could protect tumor cells from lymphocyte-mediated lysis.
For these experiments, cells were prepared from the spleens of C3Hf/Bu mice that had been bearing Fsa tumors for 14-2 1 d. These spleen cells are known to possess anti tumor activity as measured in a Winn assay (8) . The ability of the cells to iyse Fsa cells was measured in the presence and absence of hyaluronidase by a 51Cr-release assay. The results of four separate experiments are presented in Table II . Hyaluronidase did not effect Na51CrO4 uptake by tumor cells; it did not significantly increase the 51Cr released by tumor cells cultured with normal spleen cells. It did, however, in all experiments, enhance the SlCr released by Fsa cells in the presence of specifically immune spleen cells; the average increase in lysis being around threefold. The enhanced killing of Fsa cells by immune spleen cells in the presence of hyaluronidase was most obvious when nylon wool nonadherent (T-cell enriched) spleen cell populations were used (exps. 3 b and 4 b; Table II); the major reason being that T-cellenriched preparations displayed less nonspecific cytotoxicity than did the unseparated spleen cells. The cytotoxic action of immune spleen cells in the presence of hyaluronidase was immunologically specific in that, in the four experiments, we found no enhanced cytotoxicity against C3Hf/Bu adenocarcinoma IM cells when the enzyme was added (data not shown). These experiments show that the hyaluronidase-sensitive zones around tumor cells, in preventing immune lymphocytes from approaching their cell membranes, can protect them from specific cell-mediated cytolysis in vitro.
Discussion
The results show that, when cultured in vitro, cells from a C3Hf/Bu fibrosarcoma are surrounded by zones that particles cannot penetrate and that these zones, which are removed by hyaluronidase, can protect the cells from lysis by immune lymphocytes. A variety of other sarcoma and carcinoma cells as well as normal cells had similar exclusion zones; the lymphoblastoid cell lines that we tested did not.
There are only a few reports in the literature of similar phenomena, a fact that is perhaps surprising. Halos of a similar thickness have been noted on human synovial cells (3, 4) and their presence considered sufficient to protect such cells against leukocyte-induced damage (5) and to inhibit viral adherence (13) . A similar reaction with erythrocytes has been attributed to human polymorphonuclear leukocytes (14) but the hyaluronidase-sensitivity of the halo was not investigated in that paper. We have been unable to find reports of exclusion zones around tumor cells. We believe the reason for the lack of such reports is that they are difficult to visualise. They appear only 2 h after the cells are in culture and their identification requires indicator particles to be present at the correct concentration.
The nature of the halo is largely unknown. The evidence that we have is most compatible with its being a gel-like coat extending beyond the filopodia, encompassing the cell mass and being composed in part of hyaluronic acid. Very low concentrations of this glycosaminoglycan, perhaps complexed with protein and other polysaccharides (15) could form coats with properties consistent with those we have described as it is known that hyaluronic acid is heavily hydrated (16) . Support for this view comes II Effector:target cell ratios. ¶ Lysis in the presence of hyaluronidase divided by lysis in the absence of hyaluronidase: Statistically significant increases (P < 0.05; Student's t test) are shown by a. Where lysis was <10%, then 10% was used for the calculation of the increase. ** T-cell enriched .-nylon wool nonadherent. ~:~ Very occasionally high cytotoxicity was found with supposedly normal spleen cells. The explanation for this is presently unknown.
from the fact that dehydration (though not fixation) removes the halos. Alternative hypotheses, for example that the barrier is due to fine, active cell processes, require to explain the exquisite sensitivity of the halos to the several different types of hyaluronidase and in particular to the highly specific, heat stable fungal hyaluronidase. The importance of these halos to the cells is hard to define. They may act as a protective mechanism against the harsh conditions in vitro, yet the cells appear not to be affected by removal of the halos with hyaluronidase. In the experimental context, we have shown that halos prevent the approach of immune effector lymphocytes to tumor cells and, in so doing, appear to protect the tumor cells against lysis. The phenomenon may therefore influence the outcome of certain microcytotoxicity assays. It is known that there are particular problems in performing 51Cr-release microcytotoxicity assays using adherent cells as targets; for such assays, lymphoblastold cell lines are most commonly used (1 7). In this regard it may be significant that we could not detect halos around any of the lymphoblastoid cell lines tested.
It is clear that the addition of hyaluronidase may under certain conditions facilitate the cytotoxic performance of immune cells against adherent cells in vitro. However, other related factors may be important in the performance of these assays; these include the extent of halo production and its chemical composition, the time at which effector cells are added with respect to the time taken for the establishment of exclusion zones by the targets, and the presence or absence of cells such as activated macrophages which may have enzymes capable of breaking down the halo.
The significance of halo formation by cells in vitro to their behavior in vivo is as yet unclear. It is however of interest that hyaluronic acid is a major component of the ground substance and as such it will be present within solid tumors and would be expected to help maintain the integrity of the tumor. Although it has been suggested that breakdown of ground substance may facilitate spread of the tumor (18), the results presented here suggest that it would be worthwhile investigating whether its removal may in fact facilitate penetration and elimination of the tumor by the host's immune defences. The presence of these halos around adherent fibrosarcoma cells appeared to protect them from lymphocyte-mediated cytolysis. Hyaluronidase treatment, which destroyed the halo and allowed lymphocytes to approach the tumor cell membrane, enhanced the cytotoxic action of immune but not of normal spleen cells.
These observations, in addition to highlighting a little-known feature of the cell surface, may also be of general relevance to the in vitro and in vivo killing of tumor cells by immune effector cells.
